NEWS   

Results of European Association for Palliative Care 17th World Congress

1-11-21-Статистика_en.JPG

On October the 5th, the Pre-Congress Session  “Development of palliative care in CIS countries” was held by Hospice Care Professionals Association at the European Association for Palliative Care (EAPC) 17th World Congress.

 

It is gratifying to note the geographically broad interest this event aroused: 122 unique viewers from 41 countries - Europe and Asia and North and South America, Africa, and Australia. There were much positive feedback and words of support from the audience. Therefore discussion will be continued at the Round Table “Organisation of Palliative Care in Post-Soviet Countries” at the Association's annual conference on November 2-3.

 

The leading experts in palliative care delivered a welcoming speech at the session: 

  • Stephen Connor, Executive Director, Worldwide Hospice Palliative Care Alliance

  • Diana Nevzorova, Chief Specialist on palliative care of the Ministry of Health of the Russian Federation, Chairman of the Board of the Hospice Care Professionals Association, Director of Scientific and Practical Center for Palliative Care, I.M. Sechenov First Moscow State Medical University 

  • Julie Ling, Chief Executive Officer of the European Association for Palliative Care 

  • Eric Krakauer, Director, Global Palliative Care Program / Physician, Division of Palliative Care & Geriatrics, Massachusetts General Hospital, Assoc Professor of Medicine and of Global Health & Social Medicine, Harvard Medical School

  • Sophia Michaelson, Executive Director, American Eurasian Cancer Alliance, Fox Chase Cancer Center

 

Leading experts in palliative and hospice care from Russia spoke at the session:

Diana Nevzorova, Helena Polevichenko (MD, PhD, Professor, Department of Oncology, Hematology and Radiation Therapy of Pirogov Russian National Research Medical University, Chief specialist on paediatric palliative care, Ministry of Health of Russian Federation, member of the Board of the Hospice Care Professionals Association), Guzel Abuzarova (MD, PhD, Head of Palliative Care Center, P. Hertsen Moscow Oncology Research Institute, Expert, Scientific and Practical Center for Palliative Care, I.M. Sechenov First Moscow State Medical University, member of the Board of the Hospice Care Professionals Association), Olga Osetrova (MD, Head of the Autonomous Non-Profit Organization "Samara Hospice", member of the Board of the Hospice Care Professionals Association, Chief Specialist on palliative care of the Volga Federal District, member of the Board of the Hospice Care Professionals Association), Alexander Sidorov (MD, PhD, Head of Pharmacognosy and Pharmaceutical Technology Department, Yaroslavl' State Medical University, Ministry of Health of Russia, Senior Researcher, Scientific and Practical Center for Palliative Care, I.M. Sechenov First Moscow State Medical University), as well as CIS colleagues:

 

  • Olga Mychko, Republic of Belarus, Head of the Department of Planning and Organization of Palliative Care, State Institution “N. N. Alexandrov National Cancer Centre Of Belarus”, chief specialist of the Ministry of Health of the Republic of Belarus for palliative care

  • Natalia Carafizi, Republic of Moldova, Executive Director, Foundation "Hospice Angelus Moldova"

  • Gulnara Kunirova, Republic of Kazakhstan, President of the Kazakhstan Association for Palliative Care, Member of the Board of Directors of the IAHPC, Executive Director of the “Together Against Cancer” Foundation

  • Zafar Huseinov, Republic of Tajikistan, MD, PhD, Professor, Chief Oncologist of the Ministry of Health and Social Protection of the Republic of Tajikistan, Director of the Republican Cancer Research Center of the Ministry of Health and Social Protection of the Republic of Tajikistan

 

The experts discussed CIS countries’ health policies in education and research on palliative and hospice care and the country’s professional communities’ functioning. The meeting resulted in the adoption of the Session Declaration, in which symposium participants called for concerted efforts to develop mutually beneficial training programs, strategic planning of clinical services, research and clinical guideline collaborations, and scientific conferences for PC clinicians from CIS countries. Full text of the Declaration is available HERE.

 

The recording of the Session can be viewed HERE.

 

Hospice Care Professionals Association organised the event in cooperation with the Worldwide Hospice Palliative Care Alliance, the American Eurasian Cancer Alliance (AECA), with the support of the European Association for Palliative Care (EAPC).

European Association for Palliative Care 17th World Congress

20-09-21-eng.png

Dear Colleagues! 

 

On October 5, from 12:30 to 14:00 (Moscow time), we invite you to participate in the Online Pre-Congress Session “Development of palliative care in CIS countries” of the European Association for Palliative Care 17th World Congress. 

The Hospice Care Professionals Association organises the event in cooperation with the Worldwide Hospice Palliative Care Alliance the American Eurasian Cancer Alliance (AECA), with the support of the European Association for Palliative Care (EAPC) 

Leading experts in hospice and palliative care from Russia, USA, Kazakhstan, Moldova, Belarus and Tajikistan will take part in the session.

The specialists will share their countries' health policy in education and research on palliative and hospice care and work of the country professional communities. This meeting was initiated to exchange experience in the CIS countries and make joint decisions on the necessary changes in the development of country strategies in palliative care. 

Session moderators:  

Stephen Connor - Executive Director of the Worldwide Hospice Palliative Care Alliance 

Diana Nevzorova -  Chairman of the Board of the Hospice Care Professionals Association, Chief Specialist on palliative care of the Ministry of Health of the Russian Federation, Director of Scientific and Practical Center for Palliative Care, I.M. Sechenov First Moscow State Medical University  

 

The session program: 

For more information about the event and registration: 

https://www.eapc-2021.org/development-in-cis-countries

The Association signed an agreement on cooperation with
the world's leading communities

16-09-21-eng.png

Dear colleagues! 

We are pleased to announce that on September 7, a Memorandum of Understanding was signed between the Hospice Care Professionals Association (HPCA), the Worldwide Hospice Palliative Care Alliance (WHPCA) and the American Eurasian Cancer Alliance (AECA). The agreement establishes mutual intentions for further cooperation in promoting research, education, as well as philosophy of palliative care. For several years now, WHPCA and AECA have been actively participating in the annual Conferences of the HPCA, the clinical case studies, the scientific program of the educational course on palliative care for physicians, collaborate in research and scientific publications.

Cooperation with leading international organizations allows to interact more effectively in experience exchange with foreign specialists, to keep abreast of current trends in world palliative care, and to help improve the standards for the provision and organization of palliative care in Russia. We are certain that this cooperation will be long-term, fruitful and mutually beneficial.

medconf21-en.png

Dear colleagues! 

 

We are happy to announce that the VII Annual Conference with international participation "Development of palliative care for adults and children" will be held on 2-3 November 2021. 

 

The registration will be opened on August the 1st. Participation is free. The program of the event is planned for accreditation in the Council of Continuing Medical Education. 

 

The Conference will be held in a hybrid format (in-person and online), depending on the epidemiological situation in Moscow.  

Co-organizer of the event: First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) with the support of the Ministry of Health of the Russian Federation and Presidential Grants Fund. 

Partners of the Conference: Worldwide Hospice Palliative Care Alliance (WHPCA) and American Eurasian Cancer Alliance (AECA). 

 

Find more detailed information on the conference website: medconf.pro-hospice.ru. The materials will be updated, follow our publications. 

 

About the event: 

Annual Conference with international participation "Development of palliative care for adults and children" of the Russian Hospice Care Professionals Association is the largest educational event in Russia for specialists providing care to adults and children with severe progressive and life-limiting diseases. 

 
Group photo_ToT course on palliative car

The Hospice Care Professionals Association (HCPA) continues the two-year course on palliative care launched in 2020 for medical universities’ teachers. 

At the end of 2020, the HCPA and the Federal Scientific and Practical Center for Palliative Medical Care of Sechenov University, with the support of the Global Palliative Care Program of Massachusetts General Hospital/Harvard Medical School and the World Health Organization Regional Office for Europe, conducted an educational online-course with teachers of 9 medical universities of the Russian Federation. Starting from April 2021, the ToT course’s lecturers will take part in palliative care programs in participating universities.

 

Our lecturers: Eric Krakauer (Harvard Medical School), Stephen Connor (WHPCA), Tom Smith (Johns Hopkins University), Diana Nevzorova (HCPA), Eugenia Krotova (USA), Galina Khemlina (USA), Guzel Abuzarova (Moscow), Alexander Sidorov (Yaroslavl’), Olga Osetrova (Samara), Egor Larin (Moscow), Kudrina Oksana (Sechenov University). 

 
открытие.jpg

The American Eurasian Cancer Alliance, an active partner and associate of the Hospice Care Professionals Association, is celebrating its 20th anniversary this year!

AECA20.jpg

The Alliance is committed to improving the quality of life and treatment of those facing cancer, uniting physicians and researchers’ efforts in the North American and Eurasian regions, developing international cooperation in cancer treatment and research.

An essential area of ​​the Alliance's activities is in palliative care for cancer patients. For several years now, the Alliance has been actively supporting educational and scientific events of our Association. 

 

American Eurasian Cancer Alliance special edition Newsletter

 

The Hospice Care Professionals Association congratulates its partner on the anniversary and wishes him further success in its worthy activity! 

 
Group photo_ToT course on palliative car

At the end of 2020, the Hospice Care Professionals Association (HCPA) and the Federal Scientific and Practical Center for Palliative Medical Care of Sechenov University with the support of the Global Palliative Care Program of Massachusetts General Hospital/Harvard Medical School and the World Health Organization Regional Office for Europe and the assistance of the American Eurasian Cancer Alliance (AECA) and the World Hospice Palliative Care Alliance (WHPCA) conducted a large-scale educational online project for palliative care teachers of medical universities of Russia.

The course ТоТ (Training/teaching of Teachers) was attended by 22 employees of departments, where palliative care is being taught, from 9 medical educational institutions of different cities - St. Petersburg, Chelyabinsk, Tyumen, Nizhny Novgorod, Saransk, Kazan, Yaroslavl, Ryazan, Moscow take place.

 

The course was lectured by international and Russian experts and teachers, including Eric Krakauer (Harvard Medical School), Stephen Connor (WHPCA), Tom Smith (Johns Hopkins University), Diana Nevzorova (HCPA). The program covered various aspects of providing palliative care and the specifics of teaching this discipline. Particular attention was paid to the exchange of experience, discussions and interaction of participants in small groups. The course also included a detailed survey of the participants’ teaching experience, beliefs, and preferences, exploring their own “strong” and “weak” topics and difficulties in teaching palliative care.

 

The experience of the first ToT course, feedback from participants and questionnaires provided a factual basis for improving the course and tailoring it to the profile of the Russian PC teacher in order to meet best his or her needs, interests, knowledge gaps and the specifics of teaching at various medical universities in the country.

 

The importance of quality teaching for such a multifaceted discipline as palliative care, especially for the teachers themselves, is difficult to overestimate. This defines the importance of the project for the global goal of improving the quality and volume of teaching PC in the Russian Federation, which is especially relevant given its active development and the growing need for professional staff. 

The organisers of the course decided to conduct the course annually.

 
 
unnamed.jpg

 A population survey on the prevalence of various forms of tobacco use among indigenous peoples of Russia. Forming a Population-Based Smoking Prevention, Tobacco Involvement and Harm Reduction Strategy.

The Russian Federation ranks fifth in the world in the number of tobacco smokers. The Russian government is making greater efforts to fight this, including under the aegis of the World Health Organization's tobacco control initiatives. ORBI Stroke Foundation actively participates in WHO initiatives and makes it a priority to support limiting tobacco use as one of the serious factors of stroke.

A new study published by a team of researchers in the journal World Epidemiology found that the most important indicators associated with smoking initiation that need further regulatory initiatives are smoking initiation age, sex, smoking by pregnant women and young mothers, and tobacco use by the older age group.

Despite the fact that in Russia there is a downward trend in smoking in the general population, in the territories of the Far North, Caucasus, remote regions of Eastern Siberia and the Far East, due to great remoteness, low media accessibility and, especially, due to traditional ways of life, there is no trend to decrease tobacco smoking. Indigenous and minority peoples living in these territories are at greater risk and need additional measures to protect them from smoking.

In a study conducted by the working group, together with volunteers from the ORBI Stroke Foundation, 45 papers with a focus on small indigenous peoples were found and analyzed from an array of international publications to estimate the prevalence of tobacco smoking and the dynamics of tobacco use in Russia. The research team found that smoking rates varied widely depending on age, indigenous ethnicity, gender, and the remoteness of the area in which the various ethnic groups lived.

Smoking has been found to be disproportionately high among indigenous peoples. For example, one study conducted among residents of the Yamal-Nenets Autonomous Region, covering the period from 1990 to 2003, reported that 92.7% of men smoked, while another study found that in 2015 there were 23.7% of female smokers among Evenks. Unfortunately, the relatively small amount of research on Indigenous smoking has made it difficult to analyze changes in Indigenous smoking prevalence over time.

Researchers could not find evidence that there were targeted and personalized anti-smoking programs in remote regions where most indigenous peoples live. Unfortunately, there is also no mention of cessation programs developed with any indigenous groups to ensure that programs are culturally adapted so that tobacco control measures are most effective, as recommended by the WHO Framework Convention.

"We would like to show the relevance of the need for further research on tobacco use among Indigenous Peoples and, together with government agencies, socially oriented non-profit organizations and health authorities, present options for effective tobacco control measures among Indigenous Peoples, residents of remote rural areas, especially among people with low income," the researchers say.

"International evidence shows that interventions developed with the participation of smaller ethnic groups can provide proportionately greater reductions in smoking-related harm for them. Working with more than 45 small indigenous peoples living in Russia, it will be especially important to identify the most effective interventions that will improve their health," the scientists said.

 

Dr. Alexander Merkin

Academy of Postgraduate Education.

 

Dr. Mareva Glover

Director, Center for Research Excellence: Sovereignty and Smoking among Indigenous Peoples.

Dr. Igor Anatolievich Nikiforov

Academy of Postgraduate Education.

Dr. Artem Nikolaev

Head Doctor of NIKAMED Ltd.

Dr. Alexander Komarov

Executive Director of "ORBI" Stroke Foundation

Director, National Center for Development of Social Support and Rehabilitation Technologies "Doverie".

 
cancer-research-uk.jpg

When the coronavirus outbreak began, information about the mysterious virus that caused COVID-19 was scarce.

Governments and health services alike had to act on relatively limited information about the outbreak, while experts hurried to gather data on how the virus behaves and spreads, and who was most at risk.

Throughout this period of uncertainty – which severely affected cancer servicetrials and research – people were being diagnosed with, or treated for cancer and millions were living the disease. And one of the big questions was – does having cancer affect someone’s risk of developing severe COVID-19 symptoms?

Now, as we enter our third lockdown, we now have a clearer picture of how COVID-19 affects people with cancer. Information that will be invaluable in supporting people with cancer during future waves of COVID-19, and in helping people understand their individual risk.

COVID-19 severity in people with cancer

Because mass testing wasn’t available at the start of the pandemic, most of the evidence we have comes from studies involving people who were admitted to hospital.

It’s clear from many of these studies that patients with COVID-19 admitted to hospital during the first wave were at risk of lung complications, needing intensive care and, sadly, death. A similar pattern emerged when looking at evidence involving people with cancer more specifically.

But does having cancer increase someone’s risk of developing severe COVID-19 symptoms? It turns out that’s a tricky question to untangle.

We know that in the general population, someone’s age, sex and underlying health conditions (such as cardiovascular disease) are linked to COVID-19 severity. Researchers have found that similar factors are also associated with COVID-19 severity in people with cancer. Because cancer is more common in older people, and people with cancer often have other health conditions as well as cancer (comorbidities), it can be difficult to unpick whether having cancer itself increase someone’s risk of developing severe COVID-19 symptoms, but researchers have been trying.

Results from a study of 20,000 hospital inpatients that took age, sex and some comorbidities into account found that having cancer was still associated with an increased risk of dying whilst still in hospital compared to COVID-19 patients without cancer, though the risk was lower than for people with other conditions like liver disease or dementia.

These results highlight the importance of maintaining COVID-19 protected spaces in hospitals for cancer tests, treatment and care, as we’ve blogged about before. But it may be that looking at people with cancer collectively isn’t the most helpful view, as risk may vary depending on the type of cancer someone has, the type of treatment they’re undergoing and how advanced their cancer is.

COVID-19 in different types of cancer

During the first wave of the pandemic, people with blood cancer were advised to shield as they may be at higher risk of worse outcomes from COVID-19. This is because cancers of the blood or bone marrow – such as lymphoma, leukaemia and myeloma – can lower your ability to fight infection by affecting your immune system.

Findings from the UK Coronavirus Cancer Monitoring Project (UKCCMP), which covered 61 UK centres, suggest that people with blood cancer are overrepresented in the group of people with cancer who tested positive for the virus – meaning they may be more likely to catch COVID-19 than people with other cancer types.

And research so far suggests that people with blood cancer are more likely to have severe COVID-19 compared with those diagnosed with solid tumours. However, experts say that studies haven’t factored in other comorbidities and larger numbers are needed to analyse the risk associated with individual blood cancers.

The SOAP study has looked at the immune response to the virus in people with solid and blood cancers. The findings of this study suggest that people with blood cancers may have a more variable response with some patients struggling to clear the virus. Read more about what this could mean for COVID-19 vaccination in our COVID-19 vaccine and cancer blog

Researchers have also been looking into if people with lung cancer might be at higher risk of severe COVID-19. A few small studies have reported poor outcomes for a small cohort of patients with lung cancer and COVID-19.

But the UKCCMP study reported that the proportion of people who died after testing positive for COVID-19 was not significantly higher for patients with lung cancer than for patients with other types of cancer. One study has also reported current or past smoking as a risk factor for severe COVID-19 in people with lung cancer, but larger studies are needed to confirm this finding.

COVID-19 in people with cancer having different types of cancer treatment

Cancer treatment was heavily disrupted during the first wave of COVID-19, with many having their treatment delayed or altered because of the potential risks of COVID-19, or due to demands on the NHS during the pandemic.

Since the start of the pandemic, researchers have been working hard not only to monitor the impact of COVID-19 on people’s treatment, but also to understand the COVID-19 related risks of individual treatment options to help doctors and people with cancer make more informed decisions in future waves.

The biggest question mark was around surgery. Surgery was the worst hit during the first wave, mainly because of the demand for intensive care unit (ICU) beds. But there were also questions about risk, as having a big operation involving a hospital stay can make it more likely that someone will get an infection.

A large, international, ongoing study is aiming to answer questions about surgery and risk of severe outcomes from COVID-19. Findings from the COVIDSurg study have shown that having COVID-19 around the time of surgery – not just cancer surgery – leads to worse outcomes than were seen pre-pandemic, including higher rates of lung complications and higher risk of death. This initial data mainly looked at emergency surgeries, so may not be applicable to surgery in general.

COVIDSurg has begun to look at whether having had COVID-19 affects outcomes in people undergoing suspected cancer surgery. We don’t have the full findings yet, but initial results suggest that previous COVID-19 infection can increase the risk of lung complications.

The international team has also compared outcomes for patients undergoing cancer surgery in a COVID-protected environment with those having surgery in a hospital with no defined COVID-protected pathway during the height of the first wave. And the good news is it looks like COVID-protected environments do make a difference – rates of lung complications, COVID-19 infections following surgery and deaths were low in patients treated in a COVID-protected environment. This has been backed up by several other studies suggesting that it’s safe and feasible for patients to have elective cancer surgery in COVID-protected safe spaces in the UK.

Analysis of surgery for specific types of cancer is now starting to become available. International data from the first wave of the pandemic on over 2000 patients with colon or rectal cancer showed that most of these patients did not develop COVID-19 in the period after surgery. Developing COVID-19 in the period after surgery and complications after surgery were both associated with worse outcomes for patients. 

COVIDSurg data are also now available of patients with head and neck cancers, a particular concern because of the chances of spreading infection by operating in the airway. The analysis of 1,137 patients shows that the majority did not develop COVID-19 in the period after surgery and that their outcomes were similar to those normally expected from this group of patients. While this suggests that the measures introduced to make surgery safer are working, there was an association between patients and members of the surgical team testing positive. This can probably be explained by in part by high levels of infection in the community. The data also show differences in the types of head and neck cancer patients having surgery to what you would normally expect to see suggesting that some patients received alternative treatment. 

Beyond surgery, some people with cancer have also had changes made to their systemic anticancer treatment or the way in which this treatment has been provided to try to minimise their risk. For example, a switch to an oral treatment that can be taken at home rather than in hospital, or to a different drug with fewer side effects to reduce the impact on the immune system.

Radiotherapy was perhaps the least impacted type of cancer treatment and, in some cases, was even used as a treatment option for people who couldn’t have surgery or other treatments. There were some changes to radiotherapy – some patients were able to have the same overall dose of radiation in fewer visits to the hospital, reducing the risk of being infected. 

But are patients receiving systemic anticancer therapy or radiotherapy at higher risk of severe COVID-19?

While some smaller studies of people with COVID-19 and cancer have suggested that recent systemic anticancer therapy is not associated with an increased risk of dying from COVID-19, other studies have reported an increased risk. This includes the QCOVID study, a large study using data on over 6 million adults from GP and other records to develop a tool to predict COVID-19 risk based on different factors. In this study, people receiving chemotherapy were found to be at increased risk of COVID-related hospital admission and death compared to people who hadn’t had chemotherapy in the past 12 months. Similarly, people who had radiotherapy within the last 6 months were also found to be at increased risk.  

Some studies have looked at whether recent systemic anticancer therapy might increase risk specifically in patients with blood cancers. One study suggested that the risk is higher with recent treatment, but a recent review of multiple studies found no increase in risk.  

How useful is this evidence?

Initially, evidence was limited to fairly small, single centre studies. But findings from some of the larger cohorts like COVIDSurg are now becoming available, including evidence from the UK.

The speed at which some of these studies were conceived, set up and data collected – while impressive –could have resulted in missing data. And when looking at factors associated with risk of severe disease or death in subgroups of patients, analyses may be limited by small numbers.

Finally, most of the studies have only looked at hospitalised patients, which may skew the results. And because of the way testing has been carried out in hospitals, some patients may have had unidentified asymptomatic infection, potentially affecting their outcomes. Finally the way hospitals care for people with COVID-19 has changed since the first wave, so some of this evidence may not reflect what happens now.

We’ve still got a lot to learn about this relatively new virus and how it affects people with cancer, including how prior infection affects treatment outcomes, how common less severe COVID-19 is in the cancer community and whether people with cancer could have a less effective immune response to infection or a vaccine. We’re summarising the latest COVID-19 vaccine news in a separate blog post.

With large studies ongoing, we’re learning more about people’s individual risk all the time, which will be vital to help make sure that everyone gets the right treatment and care for them during the pandemic.

Lyndsy Ambler is an early diagnosis manager at Cancer Research UK

medconf21-en-end.png

On November 2-3, 2021, the VII Annual Conference with international participation "Development of palliative care for adults and children" was held within the project "Development of the competencies of palliative care specialists".

The annual conference with international participation "Development of palliative care for adults and children" of the Hospice Care Professionals Association is the largest educational event in Russia for specialists providing care to adults and children with severe progressive and life-limiting diseases.

The conference was held online with the support of the Russian Ministry of Health and the Presidential Grants Fund.

The conference was co-organized by Sechenov University, the Worldwide Hospice Palliative Care Alliance (WHPCA) and the American Eurasian Cancer Alliance (AECA).

 

The event was broadcast:

The event met the requirements of the Commission on Continuing Medical Education and was accredited by the Council of the CME.

 

Within the scientific program, 80 lecturers from 12 countries, such as Russia, the USA, Great Britain, Ireland, Germany, Israel and the post-Soviet countries, spoke at the Conference. The vibrant and comprehensive program included 86 reports.

More than 2500 people from 12 countries participated in the conference this year.

Within the conference framework, the best specialists and organizations in the field of providing palliative care as a result of 2021 were awarded a Certificate of Merit from the Hospice Care Professionals Association.

 

In the course of the Conference, the following issues were addressed:

  • Review of the new edition of the Global Atlas of Palliative Care

  • Features of chronic pain management in palliative medicine, incl. children

  • Integration of specialised palliative care: respiratory failure

  • Nutritional support, incl. children

  • End of life care

  • Interdepartmental interaction: non-profit organisations; social protection institutions; psychological support for employees, patients, relatives

  • Organisation of palliative care in the CIS countries

  • Palliative care for patients with dementia

  • Palliative care for children with cancer, neurological pathology

  • Perinatal palliative care

  • Medical technology in patient care

 

Speaker reviews:

“I am very happy with the productive partnership! The brilliant results of this conference show great progress, great results. In my opinion, this progress can and should be shared, including in the international arena. " - Sophia Michaelson, PhD, Executive Director of the American Eurasian Cancer Alliance.

 

“What made our current conference so special was that in almost every section, where it was possible, there were mixed Russian and foreign experts. This format turned out to be useful, and it seems to me that this practice should be continued. The conference’s tone was set by Robert Twycross, who, in his presentation, demonstrated a remarkable balance between “fundamentals” and “new”. When there are too many "basics", it is not interesting for those who have been in the field of palliative care for a long time; there is too much "new" - those who know little about the "basics" do not learn anything. In this conference, in my opinion, there was an optimal balance. And since palliative care is generally about balance, therefore, in my opinion, in this regard, this is the most successful conference. " - Olga Osetrova, chief physician of the Samara Hospice Autonomous Non-profit Organization.

 

“Thank you so much for the wonderful opportunity to speak at the conference! This is a great honor for me! I read the data on the scale of the event and admire it! Organizers, well done! How many hours of work are behind everything that happened in those two days! And, of course, I would like to express my sincere admiration and gratitude to my colleagues at the symposium and all the lecturers in general! I believe that together we are a great force, and we can influence the improvement of the quality of life in general today. I will be happy to continue our collaboration! With love, Zhanna Loew, psychologist, social psychologist, specialist in gerontopsychiatry, coordinator of the social support department at the Haus Am Silberberg Senior Center"

 

Feedback from participants:

“Two days of a miracle. I work with difficult children, in fact, these are palliative children  —social protection system. A lot is being done. Much of what has been said is actively used in work. Thank you! ", Pediatrician, Boarding Home for Children with Disabilities and Disabled Children with Mental Disabilities No. 1, St. Petersburg.

“This is my first time at such an event, it is interesting, but there is so much information that it takes time to sort everything out in my head. In general, I learned a lot and will use it in my work.

Many thanks to everyone! ", Health care organiser, Kirov

“I liked the lectures very much, somehow everything has turned upside down in my heart, I looked at many things from the other angle and the desire to make the life of the people around you more beautiful, better, just do not have enough words what emotions overwhelm me after this conference, thank you, that you are, people who deal with these issues and solve them! ", nurse, Radishchev, Irkutsk region.

 

We are preparing conference materials for publication. Members of the Association will be the first to see them; in two weeks the materials will be available on our website, in the HPCA Palliative Care Forums application and on YouTube. Within six months, the HPCA Forums application will provide access to the materials of the VII Annual conference with international participation “Development of palliative care for adults and children”. You can continue to communicate with colleagues, visit the “film club”, as well as a virtual exhibition of partners with valuable materials.

Subscribe to our newsletter, Facebook and youtube channel to stay updated. You can find our upcoming events in the calendar on our website.